President & Immunovant CEO
Wed, Aug 20, 2025
Aug 20
100,000 shares @ $3.85
Increased holdings by +6.00%
121st largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
43% win rate · +1.5% median edge vs SPY (63 trades, 90-day)
Insider trade was 67% below market price